Key result
Excessive supraventricular ectopic activity, defined as >4 premature atrial complexes per hour, was associated with a significantly higher prevalence of paroxysmal atrial fibrillation (19.6% vs 2.8%).
Why the study?
Does excessive supraventricular ectopic activity (ESVEA) predict the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia?
Observational (n=208)
No
Does excessive supraventricular ectopic activity (ESVEA) predict the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia?
Absolute Event Rate: 19.6% vs 2.8%
p-value: p=<0.001
Excessive supraventricular ectopic activity on a 24-hour Holter ECG is a strong, independent predictor of paroxysmal atrial fibrillation in patients with recent cerebral ischemia, helping to identify those who warrant prolonged ECG monitoring.
May support prolonged monitoring in cerebral ischemia patients with ESVEA; leaves open whether this improves outcomes.
BACKGROUND: Detecting paroxysmal atrial fibrillation (PAF) in patients with cerebral ischemia is challenging. Frequent premature atrial complexes (PAC/h) and the longest supraventricular run on 24-h-Holter (SV-run(24 h)), summarised as excessive supraventricular ectopic activity (ESVEA), may help selecting patients for extended ECG-monitoring, especially in combination with echocardiographic marker LAVI/a' (left atrial volume index/late diastolic tissue Doppler velocity). METHODS: Retrospective analysis from the prospective monocentric observational trial Find-AF (ISRCTN-46104198). Patients with acute stroke or TIA were enrolled at the University Hospital Göttingen, Germany. Those with sinus rhythm at presentation received 7-day Holter-monitoring. ESVEA was quantified in one 24-hour interval free from PAF. Echocardiographic parameters were assessed prospectively. RESULTS: PAF was detected in 23/208 patients (11.1%). The median was 4 [IQR 1; 22] for PAC/h and 5 [IQR 0; 9] for SV-run(24 h). PAF was more prevalent in patients with ESVEA: 19.6% vs. 2.8% for PAC/h >4 vs. ≤ 4 (p<0.001); 17.0% vs. 4.9% for SV-run(24 h >5) vs. ≤ 5 beats (p = 0.003). Patients with PAF showed more supraventricular ectopic activity: 29 PAC/h [IQR 9; 143] vs. 4 PAC/h [1]; [14] and longest SV-run(24 h = 10) [5]; [21] vs. 0 [0; 8] beats (both p<0.001). Both markers discriminated between the PAF- and the Non-PAF-group (area under receiver-operator-characteristics-curve 0.763 [95% CI 0.667; 0.858] and 0.716 [0.600; 0.832]). In multivariate analyses log(PAC/h) and log(SV-run(24 h)) were independently indicative of PAF. In Patients with PAC/h ≤ 4 and normal LAVI/a' PAF was excluded, whereas those with PAC/h >4 and abnormal LAVI/a' showed high PAF-rates. CONCLUSIONS: ESVEA discriminated PAF from non-PAF beyond clinical factors including LAVI/a' in patients with cerebral ischemia. Normal LAVI/a'+PAC/h ≤ 4 ruled out PAF, while prevalence was high in those with abnormal LAVI/a'+PAC/h >4.
No takes yet. Share an insight, caveat, or question.
Weber-Krüger et al. (2013) conducted an observational in Cerebral ischemia (acute stroke or TIA) (n=208). Excessive supraventricular ectopic activity (>4 premature atrial complexes/h) vs. ≤4 premature atrial complexes/h was evaluated on Detection of paroxysmal atrial fibrillation (p=<0.001). Excessive supraventricular ectopic activity, defined as >4 premature atrial complexes per hour, was associated with a significantly higher prevalence of paroxysmal atrial fibrillation (19.6% vs 2.8%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: